OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Jayesh Desai, Guzmán Alonso, Se Hyun Kim, et al.
Nature Medicine (2023) Vol. 30, Iss. 1, pp. 271-278
Open Access | Times Cited: 55
Jayesh Desai, Guzmán Alonso, Se Hyun Kim, et al.
Nature Medicine (2023) Vol. 30, Iss. 1, pp. 271-278
Open Access | Times Cited: 55
Showing 51-75 of 55 citing articles:
KRAS inhibitors in drug resistance and potential for combination therapy
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
Lala S. Rathod, Nikhil S. Sakle, Santosh N. Mokale
Tumori Journal (2024)
Closed Access
LRP1B associated with immune cell infiltration influenced the efficacy of immunotherapy in colorectal cancer patients
Weiming Weng, Shengquan He, Guoxiong Zhang, et al.
Clinics (2024) Vol. 79, pp. 100516-100516
Open Access
Weiming Weng, Shengquan He, Guoxiong Zhang, et al.
Clinics (2024) Vol. 79, pp. 100516-100516
Open Access
Combinations of RAS pathway inhibitors with targeted agents are active in spheroids of patient-derived cells with oncogenic KRAS variants from multiple cancer types
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zahra Davoudi, Thomas S. Dexheimer, Nathan P. Coussens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancer
Susmita Ghosh, Fan Fan, Reid T. Powell, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Susmita Ghosh, Fan Fan, Reid T. Powell, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Investigating the pathogenicity of uncommon KRAS mutations and their association with clinicopathological characteristics in patients with colorectal cancer
Riccardo Adorisio, Davide Ciardiello, Alessandra Rappa, et al.
Journal of Molecular Diagnostics (2024)
Closed Access
Riccardo Adorisio, Davide Ciardiello, Alessandra Rappa, et al.
Journal of Molecular Diagnostics (2024)
Closed Access
Bufadienolides from Chansu Injection Synergistically Enhances the Antitumor Effect of Erlotinib by Inhibiting the KRAS Pathway in Pancreatic Cancer
Yanli Guo, Yu Jin, Jie Gao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1696-1696
Open Access
Yanli Guo, Yu Jin, Jie Gao, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1696-1696
Open Access
Anti-KRAS G12C and Anti-EGFR Rechallenge in Chemotherapy-Refractory KRAS G12C–Mutated Colorectal Cancer: A Case Report
Linda Morris, Leontios Pappas, Aditya Pandey, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Linda Morris, Leontios Pappas, Aditya Pandey, et al.
JCO Precision Oncology (2024), Iss. 8
Closed Access
Current Understanding on Impact of Kirsten Rat Sarcoma Viral Oncogene Mutation on Colorectal Cancer: A Review
Shampa Pakhira, Priya Samanta, Rituparna Ghosh, et al.
(2024) Vol. 1, Iss. 1, pp. 8-13
Closed Access
Shampa Pakhira, Priya Samanta, Rituparna Ghosh, et al.
(2024) Vol. 1, Iss. 1, pp. 8-13
Closed Access
